- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01623960
Quality of Life in Adult Patients With Severe Haemophilia in Turkey (TurkHaemQoL)
June 17, 2012 updated by: M. Cem Ar, Turkish Society of Hematology
A Nationwide Multicenter Study on the Quality of Life in Adult Patients With Severe Haemophilia in Turkey
The primary aim of this study is to evaluate the overall quality of life in adult patients with severe haemophilia (an inherited bleeding disorder affecting mainly men) in Turkey and to assess the impact of certain disease and drug related factors (treatment modality, presence of viral disease, inhibitor, etc.) on the quality of life.
Study Overview
Status
Unknown
Conditions
Detailed Description
Haemophilia is an inherited bleeding disorder affecting one in 10000 male births worldwide.
People with severe haemophilia usually suffer from recurrent life threatening bleeds (e.g.
into the brain, digestive system or abdomen) and/or disabling degenerative disease of weight bearing joints (e.g.
knees, elbows and ankles)resulting from haemorrhage into the joints.
Daily activities of people with haemophilia has been shown to be dramatically hampered by the resultant joint damage.
Evaluation of quality of life issues in people with severe haemophilia would help to create awareness of their problems and limitations.
This would also set up the scene for developing policies to improve the treatment options/facilities and social life of the patients.
Current study aims to assess the quality of life of adult patients with severe haemophilia in a developing country (Turkey) by using a validated Quality of Life Questionnaire (Turkish version of Haem-A-QoL).
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: M.Cem Ar, MD, PhD
- Phone Number: +905326818890
- Email: mcemar68@yahoo.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Adult male patient with severe haemophilia followed at 10 different haemophilia centers in Turkey
Description
Inclusion Criteria:
- age equal or greater than 18 years
- male gender
- factor VIII or IX level equal or below 1%
- patients that are willing to participate and have given a written consent
Exclusion Criteria:
- age less than 18 years
- females
- factor levels above 1%
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Anticipated)
October 1, 2013
Study Completion (Anticipated)
February 1, 2014
Study Registration Dates
First Submitted
June 17, 2012
First Submitted That Met QC Criteria
June 17, 2012
First Posted (Estimate)
June 20, 2012
Study Record Updates
Last Update Posted (Estimate)
June 20, 2012
Last Update Submitted That Met QC Criteria
June 17, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- THD-HAEM-QoL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Haemophilia
-
Al-Azhar UniversityActive, not recruiting
-
University of ValenciaUnknown
-
Novo Nordisk A/SCompletedHaemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BFrance, United States, India, Mexico, United Kingdom, Netherlands, Sweden, Korea, Republic of, Spain, Switzerland, Serbia, Turkey, Bulgaria, Italy, Japan, Poland, South Africa, Croatia, Algeria, Australia, Bosnia and Herzegovina, ... and more
-
Novo Nordisk A/SCompletedEpidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (HAEMOcare)Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BIndia, Morocco, South Africa, Oman
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BSpain
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Novo Nordisk A/SWithdrawnHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsSpain, Canada, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsBrazil